Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.360, 2002-01, pp. : 10-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Management of cutaneous T-cell lymphoma
By Duhovic Chris Child Fiona Wain E Mary
Clinical Medicine, Vol. 12, Iss. 2, 2012-04 ,pp. :
Access to resources
Recommend
Denileukin diftitox effective in relapsed/refractory B-cell NHL
Inpharma, Vol. 1, Iss. 1460, 2004-01 ,pp. :
Efalizumab: Progression of cutaneous T-cell lymphoma: case report
Reactions Weekly, Vol. 1, Iss. 1238, 2009-01 ,pp. :
Panobinostat is promising for the treatment of patients with cutaneous T-cell lymphoma
Inpharma, Vol. 1, Iss. 1653, 2008-01 ,pp. :
Guidelines for the management of cutaneous T-cell lymphoma have been released in the UK.
Inpharma, Vol. 1, Iss. 1420, 2004-01 ,pp. :